Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Open-market buy Director bought 5,000 shares at $1.50 ($7,500)
  2. 4 Open-market buy President and CEO bought 700 shares at an average $1.59 ($1,110)
  3. 4 Open-market buy President and CEO bought 1,600 shares at an average $1.37 ($2,184)
  4. 4 Open-market buy President and CEO bought 5,000 shares at $1.33 ($6,650)
  5. 4 Open-market buy President and CEO bought 1,500 shares at $1.46 ($2,190)
  6. 4 Open-market buy President and CEO bought 3,000 shares at $1.45 ($4,350)
  7. 4 Open-market buy President and CEO bought 1,000 shares at $1.45 ($1,450)
  8. 4 Open-market buy Director bought 18,000 shares at an average $1.89 ($33,960)
  9. 4 Open-market buy Chief Financial Officer bought 500 shares at $1.90 ($950)
  10. 4 Open-market buy Director bought 7,000 shares at an average $1.89 ($13,250)
  11. 4 Open-market buy Chief Financial Officer bought 750 shares at $1.90 ($1,425)
  12. 4 Open-market buy President and CEO bought 5,000 shares at $2.03 ($10,150)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4/A Exercise or conversion Vice President of Quality acquired 807,591 shares (option exercise)
  19. 4 Exercise or conversion Vice President of Quality acquired 823,125 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 16 of 23 · 442 filings